Stay updated with breaking news from 91307c10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
United Therapeutics Co. (NASDAQ:UTHR – Get Rating) EVP Paul A. Mahon sold 6,000 shares of the business’s stock in a transaction dated Thursday, June 1st. The shares were sold at an average price of $209.11, for a total value of $1,254,660.00. Following the completion of the transaction, the executive vice president now directly owns 36,599 […]
American International Group Inc. reduced its holdings in United Therapeutics Co. (NASDAQ:UTHR – Get Rating) by 1.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 70,974 shares of the biotechnology company’s stock after selling 843 shares during the quarter. American International Group […]
Tekla Capital Management LLC lessened its stake in United Therapeutics Co. (NASDAQ:UTHR – Get Rating) by 2.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 115,077 shares of the biotechnology company’s stock after selling 2,300 shares during the quarter. […]
StockNews.com initiated coverage on shares of United Therapeutics (NASDAQ:UTHR – Get Rating) in a report released on Thursday morning. The firm issued a strong-buy rating on the biotechnology company’s stock. Several other analysts also recently commented on the stock. HC Wainwright reiterated a buy rating and issued a $300.00 price target on shares of United […]
StockNews.com began coverage on shares of United Therapeutics (NASDAQ:UTHR – Get Rating) in a research report report published on Thursday. The brokerage issued a strong-buy rating on the biotechnology company’s stock. Several other research analysts have also weighed in on UTHR. HC Wainwright reissued a buy rating and issued a $300.00 price objective on shares […]